How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

462

HTML

3247

Figures (1-5)

156

Tables (1-4)

165

Sum=4030

Aug 14, 2011 (publication date) through Apr 18, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Aug 14, 2011; 17(30): 3479-3486
Published online Aug 14, 2011. doi: 10.3748/wjg.v17.i30.3479

Table 1 Levels of evidence and strength of recommendation

Levels of evidence
1	Randomized clinical trials and/or meta-analyses
2	Single randomized clinical trail
3	Prospective observational studies
4	Retrospective studies
5	Cross-sectional surveys and descriptive studies
6	Opinion of experts in guidelines or consensus
Strength of recommendations
A	Strong (levels of evidence 1 and 2)
B	Relatively strong (levels of evidence 3, 4 and 5)
C	Weak (level of evidence 6)

Citation: Mirici-Cappa F, Caraceni P, Domenicali M, Gelonesi E, Benazzi B, Zaccherini G, Trevisani F, Puggioli C, Bernardi M. How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. World J Gastroenterol 2011; 17(30): 3479-3486
URL: https://www.wjgnet.com/1007-9327/full/v17/i30/3479.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i30.3479